Kite Pharma Inc. buy melinda
Start price
02.04.16
/
50%
€44.22
Target price
08.08.16
€57.73
Performance (%)
19.54%
End price
08.08.16
€52.86
Summary
This prediction ended on 08.08.16 with a price of €52.86. The BUY prediction by melinda finished with a performance of 19.54%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kite Pharma Inc. | - | - | - | - |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% | 65.851% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% | 93.298% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% | 89.079% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% | 71.942% |
Comments by melinda for this prediction
In the thread Kite Pharma Inc. diskutieren
Stier
Kite Pharma, Inc. betreibt als klinisches Praktikum Biotechnologie - Unternehmen, qui in der Entwicklung und Vermarktung neuartiger Krebs immunotherapeutic Produkte mit Fokus auf technisch autologe T - Zell - Therapeutika beschäftigt Gezielte , um verschiedene Arten von Tumor.
(Vom Mitglied beendet)
Stopped prediction by melinda for Kite Pharma Inc.
Kite Pharma Inc.
Start price
Target price
Perf. (%)
€160.57
31.08.17
31.08.17
€166.87
05.10.17
05.10.17
0.99%
05.10.17
05.10.17


